DeepSTARR predicts enhancer activity from DNA sequence and enables the <i>de novo</i> design of enhancers

Bernardo P. de Almeida(Research Institute of Molecular Pathology), Alexander Stark(Research Institute of Molecular Pathology), Michaela Pagani(Research Institute of Molecular Pathology), Franziska Reiter(Research Institute of Molecular Pathology)
bioRxiv (Cold Spring Harbor Laboratory)
October 7, 2021
Cited by 11


Related Papers